<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2021-12-2-92-95</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1361</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORT</subject></subj-group></article-categories><title-group><article-title>Ошибки в лечении высокодифференцированного рака щитовидной железы как междисциплинарная проблема</article-title><trans-title-group xml:lang="en"><trans-title>Errors in the treatment of highly differentiated thyroid cancer as a multidisciplinary problem</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4874-7835</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волкова</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Volkova</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Волкова Наталья Ивановна, д.м.н, проф., заведующая кафедрой внутренних болезней №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Natalya I. Volkova, Dr. Sci. (Med.), Professor, Head of Department of internal diseases №3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">n_i_volkova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6592-1607</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Меренкова</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Merenkova</surname><given-names>M. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Меренкова Мария Дмитриевна, ординатор 2-го года обучения, кафедра внутренних болезней №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Maria D. Merenkova, 2nd year resident, Department of internal diseases №3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">merenkovamaria5@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>04</day><month>07</month><year>2021</year></pub-date><volume>12</volume><issue>2</issue><fpage>92</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Волкова Н.И., Меренкова М.Д., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Волкова Н.И., Меренкова М.Д.</copyright-holder><copyright-holder xml:lang="en">Volkova N.I., Merenkova M.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1361">https://www.medicalherald.ru/jour/article/view/1361</self-uri><abstract><p>Высокодифференцированный рак щитовидной железы является распространённым эндокринным новообразованием с благоприятным прогнозом. Однако ошибки в лечении данной патологии могут значительно ухудшить качество жизни пациента.</p><p>Пациентка В., 65 лет, в 2015 г. перенесла операцию по поводу папиллярного рака щитовидной железы с травматизацией возвратного нерва. В последующем, через 6 месяцев, была проведена РЙТ с недостаточной дозой РЙ и назначен левотироксин в тиреотоксической дозировке, что привело к развитию нарушения ритма по типу фибрилляции предсердий (ФП). На протяжении всего периода после оперативного лечения биохимической ремиссии достичь не удалось, а в 2019 г. на контрольном УЗИ обнаружена лимфаденопатия передне-шейных лимфатических узлов и метастазы в легких.</p></abstract><trans-abstract xml:lang="en"><p>Highly diﬀerentiated thyroid cancer is a common endocrine neoplasm with a favorable prognosis. However, errors in the treatment of this pathology can signiﬁcantly worsen the patient’s quality of life.</p><p>Patient V., 65 years old, underwent an operation for papillary thyroid cancer with an injury to the recurrent laryngeal nerve in 2015. Only 6 months later, RAI therapy was performed with an insuﬃcient dose of RI, and levothyroxine was prescribed at a thyrotoxic dose, which led to the development of AF. Throughout the entire period after surgical treatment, biochemical remission could not be achieved, and in 2019, a control ultrasound scan revealed lymphadenopathy of the anterior cervical lymph nodes and metastases in the lungs.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак щитовидной железы</kwd><kwd>радиойодтерапия</kwd><kwd>тиреоидэктомия</kwd><kwd>метастазы</kwd><kwd>осложнения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>thyroid cancer</kwd><kwd>radioiodine therapy</kwd><kwd>thyroidectomy</kwd><kwd>metastases</kwd><kwd>complications</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Эндокринология: национальное руководство. Под ред. И.И. Дедова, Г.А., Мельниченко. - М.: ГЭОТАР-Медиа, 2019.</mixed-citation><mixed-citation xml:lang="en">Dedova I.I., Mel'nichenko G.A., eds. Endokrinologiya: natsional'noye rukovodstvo. M.: GEOTAR-Media, 2019. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Diﬀerentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Diﬀerentiated Thyroid Cancer. // yroid. – 2016. – V.26(1). – P.1-133. DOI: 10.1089/thy.2015.0020</mixed-citation><mixed-citation xml:lang="en">Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Diﬀerentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Diﬀerentiated Thyroid Cancer. // yroid. – 2016. – V.26(1). – P.1-133. DOI: 10.1089/thy.2015.0020</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ассоциация онкологов России. Российское общество специалистов по опухолям головы и шеи. Ассоциация эндокринных хирургов. Российская ассоциация эндокринологов. Клинические рекомендации. Высокодифференцированный рак щитовидной железы. – 2020.</mixed-citation><mixed-citation xml:lang="en">Assotsiatsiya onkologov Rossii. Rossiyskoye obshchestvo spetsialistov po opukholyam golovy i shei. Assotsiatsiya endokrinnykh khirurgov. Rossiyskaya assotsiatsiya endokrinologov. Klinicheskiye rekomendatsii. Vysokodiﬀerentsirovannyy rak shchitovidnoy zhelezy. 2020 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ruel E., Thomas S., Dinan M., Perkins J.M., Roman S.A., Sosa J.A. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. // J Clin Endocrinol Metab. – 2015. V.100(4). – P.1529-36. DOI: 10.1210/jc.2014-4332</mixed-citation><mixed-citation xml:lang="en">Ruel E., Thomas S., Dinan M., Perkins J.M., Roman S.A., Sosa J.A. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. // J Clin Endocrinol Metab. – 2015. V.100(4). – P.1529-36. DOI: 10.1210/jc.2014-4332</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
